Theory-based Social Media Intervention for Non-medical Use of Prescription Opioids in Young Adults

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-25
SponsorUniversity of South Carolina

About this trial

Brief Summary

The purposes of this study are to develop and implement a peer-led intervention program on Instagram for promoting prescription opioid use management and fostering psychosocial skills among young adults who engage in non-medical use of prescription opioids in the United State. The specific aims of the study include:

(1) To implement and test the feasibility of the 12-week peer-led intervention modules on Instagram among young adults who are randomly assigned to either receive the intervention (intervention group) or not receive the intervention (control group)

Participants who are assigned to the intervention group will be paired with a peer leader and attend to peer-guided interactive modules on Instagram over 12 weeks. They will complete an online survey at 1st week and 12th week, as well as brief evening surveys every two days during the intervention. The control group will not take part in intervention activities but will complete an online survey at 1st week and 12th week.

Eligibility criteria

Qualifiers

aged 18-25 years

from the U.S.

can read and speak English

engage in non-medical use of prescription opioids in the past three months: taking prescription opioids without a doctor's prescription/taking more doses of prescription opioids than what a prescription allows/using prescription opioid for reasons other than a medical purpose

Disqualifiers

receiving substance use interventions in the past three months

are diagnosed with substance use disorders

are not proficient in English

Trial design

Treatments tested in this trial

  • Theory-based and peer-led intervention on Instagram

Treatment groups

70 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of South Carolina

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator